| Literature DB >> 33583143 |
Linda Tognetti1, Elisa Cinotti1, Mariano Suppa2,3, Raffaella Guazzo4, Cyril Habougit5, Francesco Santi1, Gwendoline Diet2, Margot Fontaine2, Vincent Berot6, Jilliana Monnier7, Elisa Pianigiani1, Véronique Del Marmol2, Joseph Malvehy8, Jean-Luc Perrot6, Pietro Rubegni1.
Abstract
Autoimmune bullous diseases (AIBDs) still represent a considerable a source of morbidity and mortality: early identification of a specific AIBD is often difficult due to overlapping clinical and/or laboratory features and time-consuming invasive laboratory tests. We aimed to investigate the potential role of a new imaging technology, line-field confocal optical coherence tomography (LC-OCT), in the non-invasive diagnosis of AIBDs. LC-OCT was performed at lesional, perilesional and contralateral healthy sites in 30 patients, before histology and direct immunofluorescence. LC-OCT examination was able to identify the level of split (subcorneal/suprabasal/subepidermal/sublamina densa), to provide detailed images of the bulla roof morphology and content (eg, erythrocytes/acantholytic cells/polymorphonucleates). Areas of intra/subepidermal detachment were also detected also at clinically normal perilesional skin sites. LC-OCT can support physicians, real time and at bed-site, in the differential diagnosis of various AIBDs and their mimickers. Moreover, it can be used for the identification of subclinical lesions and therapy tapering.Entities:
Keywords: LC-OCT; autoimmune bullous diseases; bullous pemphigoid; non-invasive imaging; pemphigus
Mesh:
Year: 2021 PMID: 33583143 DOI: 10.1002/jbio.202000449
Source DB: PubMed Journal: J Biophotonics ISSN: 1864-063X Impact factor: 3.207